These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 36646419)

  • 1. Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
    Rodriguez-Jimenez FJ; Ureña-Peralta J; Jendelova P; Erceg S
    J Adv Res; 2023 Dec; 54():105-118. PubMed ID: 36646419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
    Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.
    Raman S; Brookhouser N; Brafman DA
    Neurobiol Dis; 2020 May; 138():104788. PubMed ID: 32032733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling amyloid beta and tau pathology in human cerebral organoids.
    Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
    Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
    Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
    Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
    Sahlgren Bendtsen KM; Hall VJ
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.
    Muratore CR; Zhou C; Liao M; Fernandez MA; Taylor WM; Lagomarsino VN; Pearse RV; Rice HC; Negri JM; He A; Srikanth P; Callahan DG; Shin T; Zhou M; Bennett DA; Noggle S; Love JC; Selkoe DJ; Young-Pearse TL
    Stem Cell Reports; 2017 Dec; 9(6):1868-1884. PubMed ID: 29153990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications.
    Essayan-Perez S; Zhou B; Nabet AM; Wernig M; Huang YA
    Neurobiol Dis; 2019 Oct; 130():104503. PubMed ID: 31202913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.
    Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y
    Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
    Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
    Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Insights into Cell Type-specific Roles in Alzheimer's Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling.
    Qu W; Canoll P; Hargus G
    Neuroscience; 2023 May; 518():10-26. PubMed ID: 35569647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
    Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
    Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.
    Lin YT; Seo J; Gao F; Feldman HM; Wen HL; Penney J; Cam HP; Gjoneska E; Raja WK; Cheng J; Rueda R; Kritskiy O; Abdurrob F; Peng Z; Milo B; Yu CJ; Elmsaouri S; Dey D; Ko T; Yankner BA; Tsai LH
    Neuron; 2018 Jun; 98(6):1141-1154.e7. PubMed ID: 29861287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Induced Pluripotent Stem Cell-Derived Neural Cells from Alzheimer's Disease Patients Exhibited Different Susceptibility to Oxidative Stress.
    Zhang L; Xu M; Ren Q; Liu G; Meng S; Xiahou K; Zhang Y; Jiang N; Zhou W
    Stem Cells Dev; 2020 Nov; 29(22):1444-1456. PubMed ID: 32988331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.
    Foveau B; Correia AS; Hébert SS; Rainone S; Potvin O; Kergoat MJ; Belleville S; Duchesne S; LeBlanc AC;
    J Alzheimers Dis; 2019; 67(3):893-910. PubMed ID: 30689579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
    Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
    Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.